Caraglia M - Search Results

1

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.

Correale P, Messinese S, Caraglia M, Marsili S, Piccolomini A, Petrioli R, Ceciarini F, Micheli L, Nencini C, Neri A, Vuolo G, Guarnieri A, Abbruzzese A, Prete SD, Giorgi G, Francini G. Correale P, et al. Among authors: caraglia m. Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783. Br J Cancer. 2004. PMID: 15150625 Free PMC article. Clinical Trial.

2

Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells.

Correale P, Caraglia M, Fabbrocini A, Guarrasi R, Pepe S, Patella V, Marone G, Pinto A, Bianco AR, Tagliaferri P. Correale P, et al. Among authors: caraglia m. Anticancer Drugs. 1995 Apr;6(2):285-90. doi: 10.1097/00001813-199504000-00013. Anticancer Drugs. 1995. PMID: 7540894

3

Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR. Caraglia M, et al. Cancer Immunol Immunother. 1993 Aug;37(3):150-6. doi: 10.1007/BF01525428. Cancer Immunol Immunother. 1993. PMID: 8392910 Free PMC article.

4

Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.

Correale P, Tagliaferri P, Guarrasi R, Caraglia M, Giuliano M, Marinetti MR, Bianco AR, Procopio A. Correale P, et al. Among authors: caraglia m. Immunol Lett. 1997 Feb;55(2):69-78. doi: 10.1016/s0165-2478(96)02687-9. Immunol Lett. 1997. PMID: 9143936

5

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.

Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera MT, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: caraglia m. Am J Clin Oncol. 1998 Feb;21(1):48-53. doi: 10.1097/00000421-199802000-00011. Am J Clin Oncol. 1998. PMID: 9499257 Clinical Trial.

6

Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.

Tagliaferri P, Guarrasi R, Caraglia M, Morelli D, Fabbrocini A, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: caraglia m. Cancer Immunol Immunother. 1998 May;46(3):121-7. doi: 10.1007/s002620050470. Cancer Immunol Immunother. 1998. PMID: 9625535 Free PMC article. Review. No abstract available.

7

Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells.

Beninati S, Gentile V, Caraglia M, Lentini A, Tagliaferri P, Abbruzzese A. Beninati S, et al. Among authors: caraglia m. FEBS Lett. 1998 Oct 16;437(1-2):34-8. doi: 10.1016/s0014-5793(98)01191-0. FEBS Lett. 1998. PMID: 9804167 Free article.

8

Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.

Caraglia M, Di Gennaro E, Barbarulo D, Marra M, Tagliaferri P, Abbruzzese A, Budillon A. Caraglia M, et al. FEBS Lett. 1999 Mar 26;447(2-3):203-8. doi: 10.1016/s0014-5793(99)00292-6. FEBS Lett. 1999. PMID: 10214946 Free article.

9

8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.

Budillon A, Di Gennaro E, Caraglia M, Barbarulo D, Abbruzzese A, Tagliaferri P. Budillon A, et al. Among authors: caraglia m. Br J Cancer. 1999 Dec;81(7):1134-41. doi: 10.1038/sj.bjc.6690820. Br J Cancer. 1999. PMID: 10584873 Free PMC article.

10

Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.

Vitale G, Tagliaferri P, Caraglia M, Rampone E, Ciccarelli A, Bianco AR, Abbruzzese A, Lupoli G. Vitale G, et al. Among authors: caraglia m. J Clin Endocrinol Metab. 2000 Mar;85(3):983-8. doi: 10.1210/jcem.85.3.6435. J Clin Endocrinol Metab. 2000. PMID: 10720027 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters